AMPs, such as cathelicidin (LL-37) and secretory leukocyte protease inhibitor (SLPI), are inhibited in CF by the overexuberant production of NE produced as a result of infection in the lung [91,92,93]. The gene discussed is SLPI; the disease is infection.